针对癌症中的多方面的BRAF:新的方向
Eamon Toye1,2,3, Alexander Chehrazi-Raffle4, Justin Hwang1,2
1Masonic Cancer Center, University of Minnesota-Twin Cities, Minneapolis, MN 55455, USA.
Oncotarget
|July 17, 2024
概括
激活BRAF突变驱动癌症的生长和抵抗力. 本综述探讨了各种BRAF变异和针对各种癌症的向治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 激活基因激活蛋白激酶 (MAPK) 途径中的激活突变是瘤发生,转移和治疗耐药性的关键驱动因素.
- MAPK通路的激活主要是由RAS和BRAF的基因组变化驱动的,BRAF作为RAS下游的效应因酶.
研究的目的:
- 讨论在人类癌症中发现的各种形式的BRAF变异.
- 审查抑制不同癌症起源患者BRAF变化的策略.
主要方法:
- 在人类癌症中对BRAF变化的文献综述.
- 分析针对BRAF的精密疗法及其有效性.
- 探索非I类BRAF修改的策略.
主要成果:
- BRAF的变化包括功能增益突变,副本数量变化和各种癌症的结构重组.
- 第I类BRAF变异 (p.V600热点突变) 在黑色素瘤,甲状腺癌和结直肠癌中被精确疗法有效准.
- 对非I类BRAF变化的抑制剂的开发和探索正在进行中.
结论:
- 了解BRAF变化的多样性对于有效的癌症治疗至关重要.
- 针对BRAF的向治疗,包括针对非I类变化的向治疗,为各种癌症提供了有希望的策略.
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Cancer Vaccines
350
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
350


